Form 4 for MGX Metagenomi Therapeutics, Inc.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-05 · accession 0000950170-24-134124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-06 | 2024-12-05 | MGX | Wapnick Pamela | CFO | S - Sale | $1.86 | -1,559 | 61.5K | -2% | -$2,900 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-05 | S | D | 1,559 | $1.86 | 61,492 | D | — | — |